ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GDR Genedrive Plc

1.675
0.00 (0.00%)
04 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.675 1.60 1.80 - 0.00 07:30:47
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0095 -1.76 9.07M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 1.68p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 17.25p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £9.07 million. Genedrive has a price to earnings ratio (PE ratio) of -1.76.

Genedrive Share Discussion Threads

Showing 5701 to 5723 of 27250 messages
Chat Pages: Latest  238  237  236  235  234  233  232  231  230  229  228  227  Older
DateSubjectAuthorDiscuss
02/2/2021
11:55
Richardp19 past 10 minutes nt to buy with HL

share price moving up more again

bunz3
02/2/2021
11:54
I tried to buy 1000 but nt with HL
richardp19
02/2/2021
11:51
He doesn't carry anything just the big mouth and lies and slandering every share that goes up, so pls try and not mention him or he be back with a revenge
amrishbhim
02/2/2021
11:51
i think the latter
wooster4
02/2/2021
11:50
hl back to NT to buy again share supply looks to be running low again with this buying
bunz3
02/2/2021
11:50
Why would anyone be short now at this juncture. Must be silly or just lying.
richardp19
02/2/2021
11:48
I imagine he's had to close his short and carry a significant loss.
janhar
02/2/2021
11:47
like how soon any sellers shares mopped up
bunz3
02/2/2021
11:46
Please don't mention his name please
amrishbhim
02/2/2021
11:43
like how any sellers shares being bought up
bunz3
02/2/2021
11:41
might see £1,20 /£1,30 Today with this buying momentum
bunz3
02/2/2021
11:39
My L2 is flashing all over the place I'm genuinely excited for this now.
richardp19
02/2/2021
11:36
1 pound should be history today.
losses
02/2/2021
11:31
30,000 share buy at 91,80
bunz3
02/2/2021
11:29
Well I enjoyed the ride with NCYT but missed the big gains as was too nervous.

not on GDR following recent updates....am in for the mid-Feb launch CEO talks of and so much more that peeps have posted above, for which thanks.

NCYT went from zip to c.£1bn company in a few months....no reason GDR can't begin to mirror that success IMO!!

DYOR and hope we can reflect back on this post in 3-4 months time and say told you so, rather than fek lost all my dough!!

DYOR

Cheers
QS99

qs99
02/2/2021
11:28
Bunz, each BC i7 running GDR beads 2 shifts 7 days a week adds £20m market cap to GDR on a 3 x revenue basis.That is working out on £10 a test which we know is higher in the US.GDR currently has a market cap of £54m so you can see how the rollout will have a HUGE effect on GDRs small market cap.
hooded claw
02/2/2021
11:23
Richard, NY Boy said NCYT was too high at £1 a share last Feb and Covid would be 'gone by summer' so he is best ignored IMHO
hooded claw
02/2/2021
11:17
are some thinking a share price around £2 or £3 might be seen in next number of weeks after last weeks rns

Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing


David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.



"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."



The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations

bunz3
02/2/2021
11:16
Any suggestions for research NY boy
richardp19
02/2/2021
11:14
I’ve been accumulating, obviously the market got wind 😁

Some good plays around +50% so far on AML, holing everything for post Covid recovery, as the vaccine roll out gathers steam

ny boy
02/2/2021
11:13
some one looks to want in possible before Mid February

so much buying pressure

bunz3
02/2/2021
11:10
Some one is loading up that's for sure
richardp19
02/2/2021
11:08
7000 share buyer still loading up with more tranches
bunz3
Chat Pages: Latest  238  237  236  235  234  233  232  231  230  229  228  227  Older

Your Recent History

Delayed Upgrade Clock